These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Kelly KE; Hertz MI; Mueller DL Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840 [TBL] [Abstract][Full Text] [Related]
10. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice. Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model. Nusair S; Or R; Junadi S; Amir G; Breuer R Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876 [TBL] [Abstract][Full Text] [Related]
12. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease. Lemaître PH; Vokaer B; Charbonnier LM; Iwakura Y; Field KA; Estenne M; Goldman M; Leo O; Remmelink M; Le Moine A Am J Transplant; 2013 Mar; 13(3):611-20. PubMed ID: 23331973 [TBL] [Abstract][Full Text] [Related]
14. Different kinetics of obliterative airway disease development in heterotopic murine tracheal allografts induced by CD4+ and CD8+ T cells. Higuchi T; Jaramillo A; Kaleem Z; Patterson GA; Mohanakumar T Transplantation; 2002 Sep; 74(5):646-51. PubMed ID: 12352880 [TBL] [Abstract][Full Text] [Related]
15. Dependence of murine obstructive airway disease on CD40 ligand. Rumbley CA; Silver SJ; Phillips SM Transplantation; 2001 Nov; 72(10):1616-25. PubMed ID: 11726820 [TBL] [Abstract][Full Text] [Related]
16. Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor. Smith CR; Jaramillo A; Lu KC; Higuchi T; Kaleem Z; Mohanakumar T Transplantation; 2001 Nov; 72(9):1512-8. PubMed ID: 11707738 [TBL] [Abstract][Full Text] [Related]
17. Induction of obliterative airway disease in murine tracheal allografts by CD8+ CTLs recognizing a single minor histocompatibility antigen. Higuchi T; Maruyama T; Jaramillo A; Mohanakumar T J Immunol; 2005 Feb; 174(4):1871-8. PubMed ID: 15699113 [TBL] [Abstract][Full Text] [Related]
18. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation. Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827 [TBL] [Abstract][Full Text] [Related]
19. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. Ferrer IR; Wagener ME; Song M; Ford ML PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369 [TBL] [Abstract][Full Text] [Related]
20. CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant. Dodd-o JM; Lendermon EA; Miller HL; Zhong Q; John ER; Jungraithmayr WM; D'Alessio FR; McDyer JF Am J Transplant; 2011 Sep; 11(9):1815-24. PubMed ID: 21827610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]